More Than 10 Percent of World’s Population Is Obese, Study ...
A study in The New England Journal of Medicine showed problem had swept the globe, including regions that […]
A study in The New England Journal of Medicine showed problem had swept the globe, including regions that […]
People in transition because of layoffs, moves, illness or new ventures turned to Obamacare’s marketplaces as a stopgap, […]
Despite limited evidence to prove its drug works, the maker of Vivitrol has used political connections and marketing […]
The first-ever charges in America call attention to the practices of a small Muslim sect, and have women […]
The agency’s request about the drug, Opana ER, may signal a more aggressive approach against prescription opioids that […]
The report, published on Thursday by the Centers for Disease Control and Prevention, also provided for the first […]
The drug, Keytruda, is the first approved for patients with tumors with a particular genetic signature, wherever they […]
The decision by the for-profit Blue Cross/Blue Shield to leave the Obamacare markets in 2018 will leave about […]
A New York Times analysis of insurance market data. Published: June 6, 2017 at 02:00AM from NYT Health […]
Like many doctors who prescribe opioids, Dr. Robert L. Wergin requires patients who receive these medications to sign […]